Arkolith/Insider Trading/MNPR/Form 4

Starr Christopher M

DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Jul 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$672K
Net Open-Market Flow
-$672K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2025Sell(S)17K$40.00$672K5K
Jul 14, 2025Option exercise(X)17K$0.01$16822K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2025Option exercise(X)17K—$00

Transaction Codes

S
Open-market sale
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-022862) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Monopar Therapeutics

Build

Ask your agent about MNPR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-25-022862"
Ask your agent
Use Arkolith to summarize insider buying and selling at Monopar Therapeutics
over the last 90 days and cite the filings.